Registry of Acute Stroke Under Novel Oral Anticoagulants - Prime "RASUNOA-Prime"

Recruiting

Phase N/A Results N/A

Summary of Purpose

The Registry of Acute Stroke Under Novel Oral Anticoagulants-Prime (RASUNOA-Prime), an investigator-initiated study, is a German multicenter, prospective, observational registry. It is performed at about 50 certified stroke-units and supported by an unrestricted grant from different pharmaceutical companies to the Heidelberg University Hospital. RASUNOA-Prime is designed to assess the emergency management of...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 1 May 2017.

1 Jun 2015 23 Aug 2015 1 Dec 2019 1 Dec 2019 1 May 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Observation: Cohort
  • Perspective: Prospective
  • Sampling: Probability Sample

Contacts

  • Timolaos Rizos, MD

  • Roland Veltkamp, Prof. Dr. med.